More on DERM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $7.85 |
|
|||
| Open | $7.72 | ||||
| 52 Wk High | $36.34 | ||||
| 52 Wk Low | $17.42 | ||||
| Day High | $8.07 | ||||
| Day Low | $7.72 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 74,564 | ||||
- B.Riley Reiterates Buy Rating on Journey Medical Corp. (DERM)
- Form 424B3 Journey Medical Corp
- Form 424B3 Journey Medical Corp
- Form EFFECT Journey Medical Corp
- Journey Medical Corp (DERM) files $150M mixed shelf
- Form S-3 Journey Medical Corp
- Journey Medical publishes Emrosi clinical trial results in dermatology journal
- Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
- Dermira (DERM) Misses Q3 EPS by 6c
- Form 10-Q Journey Medical Corp For: Sep 30
Entities mentioned with DERM
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Needham & Company | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
